Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301953 (3-(3-(4-(4,6-Dimethoxypyrimidin-2-yl)piperazin-1-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 0.190 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301980 (3-(3-(4-(4-(Trifluoromethyl)pyrimidin-2-yl)piperaz...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 0.200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301982 (Ethyl 2-(4-(3-(5-fluoro-1H-indol-3-yl)propyl)piper...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 0.270 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301963 (3-(3-(4-(4,6-Dimethylpyrimidin-2-yl)piperazin-1-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 0.290 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301984 (Ethyl 2-(4-(3-(5-cyano-1H-indol-3-yl)propyl)pipera...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 0.300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301967 (3-(4-(4-(4-Methoxy-6-methylpyrimidin-2-yl)piperazi...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 0.650 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301978 (3-(4-(4-(4-(Trifluoromethyl)pyrimidin-2-yl)piperaz...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 0.700 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301964 (5-Chloro-3-(3-(4-(4,6-dimethylpyrimidin-2-yl)piper...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 0.710 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301983 (Ethyl 2-(4-(4-(5-cyano-1H-indol-3-yl)butyl)piperaz...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 0.790 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301979 (5-Fluoro-3-(3-(4-(4-(trifluoromethyl)pyrimidin-2-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301958 (3-(4-(4-(4,6-Dimethylpyrimidin-2-yl)piperazin-1-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301957 (3-(4-(4-(4,6-Dimethylpyrimidin-2-yl)piperazin-1-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301949 (5-Chloro-3-(4-(4-(4,6-dimethoxypyrimidin-2-yl)pipe...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301966 (3-(3-(4-(4,6-Dimethylpyrimidin-2-yl)piperazin-1-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301956 (3-(3-(4-(4,6-Dimethoxypyrimidin-2-yl)piperazin-1-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.30 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301965 (3-(3-(4-(4,6-Dimethylpyrimidin-2-yl)piperazin-1-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.40 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301948 (3-(4-(4-(4,6-Dimethoxypyrimidin-2-yl)piperazin-1-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.40 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301968 (3-(3-(4-(4-Methoxy-6-methylpyrimidin-2-yl)piperazi...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301960 (3-(4-(4-(4,6-Dimethylpyrimidin-2-yl)piperazin-1-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.70 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301959 (5-Chloro-3-(4-(4-(4,6-dimethylpyrimidin-2-yl)piper...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.80 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301977 (5-Fluoro-3-(4-(4-(4-(trifluoromethyl)pyrimidin-2-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301954 (5-Chloro-3-(3-(4-(4,6-dimethoxypyrimidin-2-yl)pipe...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301951 (3-(4-(4-(4,6-Dimethoxypyrimidin-2-yl)piperazin-1-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.30 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301992 (2-(4-(3-(5-Cyano-1H-indol-3-yl)propyl)piperazin-1-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.60 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301950 (3-(4-(4-(4,6-Dimethoxypyrimidin-2-yl)piperazin-1-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.80 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301961 (3-(4-(4-(4,6-Dimethylpyrimidin-2-yl)piperazin-1-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.90 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301947 (3-(4-(4-(4,6-Dimethoxypyrimidin-2-yl)piperazin-1-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 3.30 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301955 (3-(3-(4-(4,6-Dimethoxypyrimidin-2-yl)piperazin-1-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 3.40 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301988 (2-(4-(3-(5-Cyano-1H-indol-3-yl)propyl)piperazin-1-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 3.70 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301971 (2-(4-(3-(5-Fluoro-1H-indol-3-yl)propyl)piperazin-1...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301962 (3-(3-(4-(4,6-Dimethylpyrimidin-2-yl)piperazin-1-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 4.10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301990 (2-(4-(3-(5-Fluoro-1H-indol-3-yl)propyl)piperazin-1...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 4.20 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301986 (2-(4-(3-(5-Fluoro-1H-indol-3-yl)propyl)piperazin-1...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 4.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301952 (3-(3-(4-(4,6-Dimethoxypyrimidin-2-yl)piperazin-1-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 4.80 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301991 (2-(4-(4-(5-Cyano-1H-indol-3-yl)butyl)piperazin-1-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301981 (Ethyl 2-(4-(4-(5-fluoro-1H-indol-3-yl)butyl)pipera...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 5.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301970 (3-(4-(4-(4-Cyanopyrimidin-2-yl)piperazin-1-yl)buty...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 6.20 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301972 (3-(3-(4-(4-Cyanopyrimidin-2-yl)piperazin-1-yl)prop...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 8 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301974 (2-(4-(4-(5-Cyano-1H-indol-3-yl)butyl)piperazin-1-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301975 (2-(4-(3-(5-Fluoro-1H-indol-3-yl)propyl)piperazin-1...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 12 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301987 (2-(4-(4-(5-Cyano-1H-indol-3-yl)butyl)piperazin-1-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 12 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301989 (2-(4-(4-(5-Fluoro-1H-indol-3-yl)butyl)piperazin-1-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 14 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301976 (2-(4-(3-(5-Cyano-1H-indol-3-yl)propyl)piperazin-1-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 14 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301969 (2-(4-(4-(5-Fluoro-1H-indol-3-yl)butyl)piperazin-1-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 18 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301985 (2-(4-(4-(5-Fluoro-1H-indol-3-yl)butyl)piperazin-1-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 23 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301973 (2-(4-(4-(5-Fluoro-1H-indol-3-yl)butyl)piperazin-1-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 60 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
D(2) dopamine receptor (Homo sapiens (Human)) | BDBM301950 (3-(4-(4-(4,6-Dimethoxypyrimidin-2-yl)piperazin-1-y...) | PDB UniProtKB/TrEMBL GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 110 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Cell membrane homogenates (24 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]methyl-spiperone in the absence or presence of... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
D(2) dopamine receptor (Homo sapiens (Human)) | BDBM301962 (3-(3-(4-(4,6-Dimethylpyrimidin-2-yl)piperazin-1-yl...) | PDB UniProtKB/TrEMBL GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 110 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Cell membrane homogenates (24 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]methyl-spiperone in the absence or presence of... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
D(2) dopamine receptor (Homo sapiens (Human)) | BDBM301991 (2-(4-(4-(5-Cyano-1H-indol-3-yl)butyl)piperazin-1-y...) | PDB UniProtKB/TrEMBL GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 130 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Cell membrane homogenates (24 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]methyl-spiperone in the absence or presence of... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
D(2) dopamine receptor (Homo sapiens (Human)) | BDBM301981 (Ethyl 2-(4-(4-(5-fluoro-1H-indol-3-yl)butyl)pipera...) | PDB UniProtKB/TrEMBL GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 130 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Cell membrane homogenates (24 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]methyl-spiperone in the absence or presence of... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 63 total ) | Next | Last >> |